tiprankstipranks
Aquestive Therapeutics, Inc. (AQST)
NASDAQ:AQST
US Market
AQST
Aquestive Therapeutics
RESEARCH TOOLSreports

Aquestive Therapeutics (AQST) Stock News & Sentiment

2,470 Followers
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline 
Premium
Class Action
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline 
12d ago
AQST
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting
Premium
Company Announcements
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting
14d ago
8K
AQST
Aquestive Therapeutics Announces Key Legal Leadership Transition
Premium
Company Announcements
Aquestive Therapeutics Announces Key Legal Leadership Transition
24d ago
8K
AQST
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged FDA Approval Misrepresentations for Anaphylm
Premium
Class Action
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged FDA Approval Misrepresentations for Anaphylm
25d ago
AQST
Reiterating Buy on Aquestive: Near-Term Cost Pressures Offset by Anaphylm-Driven 2027 Growth Potential and $10 Target
Premium
Ratings
Reiterating Buy on Aquestive: Near-Term Cost Pressures Offset by Anaphylm-Driven 2027 Growth Potential and $10 Target
1M ago
AQST
Aquestive Therapeutics Maps Risky Path to ANNAFILM Launch
Premium
Company Announcements
Aquestive Therapeutics Maps Risky Path to ANNAFILM Launch
1M ago
AQST
AI Execution Risks Threaten Aquestive Therapeutics’ Competitiveness and Profitability
Premium
Company Announcements
AI Execution Risks Threaten Aquestive Therapeutics’ Competitiveness and Profitability
1M ago
AQST
More AQST News >

AQST News on the Web

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Zacks
Bullish
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Insmed (INSM)
TipRanks News
Bullish
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting
TipRanks News
Neutral
Analysts Are Bullish on These Healthcare Stocks: Alumis Inc. (ALMS), Aquestive Therapeutics (AQST)
TipRanks News
Bullish
Aquestive Therapeutics completes Type A meeting with FDA for Anaphylm NDA
TipRanks News
Bullish
Aquestive Therapeutics Announces Key Legal Leadership Transition
TipRanks News
Neutral
Aquestive chief legal officer, chief compliance officer Lori Braender steps down
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
AQST
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AQST’s Media Buzz Sentiment?
1 articles about AQST were published this week. In an average week, 2.25 articles are published.
    What is AQST’s weekly average amount of articles?
    In an average week, 2.25 articles about AQST are published.
      What is AQST’s News Sentiment?
      100% of articles about AQST were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        SLPSimulations Plus
        REPLReplimune Group
        Showing the stocks with the most bullish news sentiment over the past week